1Hemandez-Salazar A, Rosales SP, Rangel-Frausto S, et al. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res,2006,37:899-902.
2Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol, 2001,137:765-770.
3Wolf R,Orion E, Marcos B, et al. Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol,2005 ,23 :171-181.
4Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet,2000,356 : 1255-1259.
5Bronnimann M, Yawalkar N. Histopathology of drug-induced exanthems: is there a role in diagnosis of drug allergy? Curr Opin Allergy Clin Immunol,2005,5:317-321.
6Roujean JC. Immune mechanisms in drug allergy. Allergol Int, 2006,55:27-33.
7Puavilai S, Chunharas A, Kamtavee S, et al. Drug eruptions : the value of oral rechallenge test and patch test. J Med Assoc Thai, 2002,85 : 263 -269.
8Knowles SR, Shear NH. Recognition and management of severe cutaneous drug reactions. Dermatol Clin, 2007,2.5:245-253.
9Mittmann N, Chan B, Knowles S, et al. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol,2006 ,7 :359-368.
10Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Arm Allergy Asthma Immunol,2006 ,97 :272-280.
